Trailing-twelve-month (TTM) revenue is $6.46 Billion with a year-over-year growth of +0.68%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,524,072,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $1,752,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-03-31 | $1,511,041,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $1,675,943,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $6,463,656,000 |
Current P/S: $11,436,388,628 market capitalization ÷ $6,463,656,000 TTM revenue = 1.77x.
Market capitalization source: FMP quote. Quote observed 2026-09-10T14:30:24.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.68B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-10T14:30:24.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Consulting | $376M | $418M | $482M | $515M | $559M | $552M |
| Events | $120M | $214M | $389M | $505M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Europe Middle East Africa | $966M | $1.1B | $1.2B | $1.3B | $1.5B | $1.7B |
| Other International | $495M | $554M | $622M |
$6.46B
$6.46 Billion
+0.68%
vs. $6.42B a year ago (TTM)
+8.10%
5 Year compound annual growth rate
1 Year
+0.68%
3 Year
+3.98%
5 Year
+8.10%
10 Year
+10.83%
15 Year
+10.88%
20 Year
+9.62%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $6.50B | +$229.84M | +3.67% |
| 2024 | $6.27B | +$360.45M | +6.10% |
| 2023 | $5.91B | +$431.11M | +7.87% |
| 2022 | $5.48B | +$741.88M | +15.67% |
| 2021 | $4.73B | +$634.56M | +15.48% |
| 2020 |
TTM Growth
+0.68%
3-Year CAGR
+3.98%
5-Year CAGR
+8.10%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-10T14:30:24.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $645M |
| Research Segment | $3.6B | $4.1B | $4.6B | $4.9B | $5.1B | N/A |
|---|
| $732M |
| $771M |
| United States And Canada | $2.6B | $3.0B | $3.6B | $3.9B | $4.0B | $4.0B |
|---|
| $4.10B |
| ($145.92M) |
| (3.44%) |
| 2019 | $4.25B | +$269.87M | +6.79% |
| 2018 | $3.98B | +$663.96M | +20.05% |
| 2017 | $3.31B | +$866.95M | +35.46% |
| 2016 | $2.44B | +$281.48M | +13.01% |
